MedTrace Logo

Web-Based Treatment for Aphasia

NCT04413136 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2021-04-14

No results posted yet for this study

Summary

This prospective randomized clinical trial implements an innovative broadband web-based treatment program for individuals with chronic aphasia, and evaluates its efficacy. The treatment, Oral Reading for Language in Aphasia (ORLA), has been shown to be efficacious when provided by a speech-language pathologist. The treatment has been computerized and the current version of ORLA uses state-of-the-art virtual therapist technology that allows the individual with aphasia to read aloud, and ultimately speak, sentences at the same time as the words are produced by a perceptive, life-like, animated computer agent, using visible speech. In this clinical trial, ORLA treatment is delivered via the internet and outcomes are compared to a placebo computer treatment.

Conditions

  • Aphasia

Interventions

BEHAVIORAL

Web-ORLA

BEHAVIORAL

Control

Sponsors & Collaborators

  • Northwestern University

    collaborator OTHER

  • University of Colorado, Boulder

    collaborator OTHER

  • Shirley Ryan AbilityLab

    lead OTHER

Principal Investigators

  • Leora R Cherney, PhD · Shirley Ryan AbilityLab

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-07
Primary Completion
2010-10-27
Completion
2011-09-29

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04413136 on ClinicalTrials.gov